Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P00451: Variant p.Val727Phe

Coagulation factor VIII
Gene: F8
Feedback?
Variant information Variant position: help 727 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Valine (V) to Phenylalanine (F) at position 727 (V727F, p.Val727Phe). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (V) to large size and aromatic (F) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In HEMA; severe. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 727 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2351 The length of the canonical sequence.
Location on the sequence: help WILGCHNSDFRNRGMTALLK V SSCDKNTGDYYEDSYEDISA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         WILGCHNSDFRNRGMTALLKVSSCDKNTGDYYEDSYEDISA

                              WVLGCHNSDFRNRGMTALLKVSSCNRNIDDYYEDTYEDIPT

Mouse                         WVLGCHNSDFRKRGMTALLKVSSCDKSTSDYYEEIYEDIPT

Pig                           WVLGCHNSDLRNRGMTALLKVYSCDRDIGDYYDNTYEDIPG

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 20 – 2351 Coagulation factor VIII
Chain 20 – 1332 Factor VIIIa heavy chain, 200 kDa isoform
Chain 20 – 759 Factor VIIIa heavy chain, 92 kDa isoform
Domain 399 – 730 F5/8 type A 2
Domain 583 – 730 Plastocyanin-like 4
Modified residue 737 – 737 Sulfotyrosine
Modified residue 738 – 738 Sulfotyrosine
Modified residue 742 – 742 Sulfotyrosine
Disulfide bond 649 – 730
Alternative sequence 9 – 2143 Missing. In isoform 2.
Beta strand 723 – 728



Literature citations
Fluorescent chemical cleavage of mismatches for efficient screening of the factor VIII gene.
Freson K.; Peerlinck K.; Aguirre T.; Arnout J.; Vermylen J.; Cassiman J.-J.; Matthijs G.;
Hum. Mutat. 11:470-479(1998)
Cited for: VARIANTS HEMA ASP-132; PHE-253; ILE-314; VAL-331; ARG-474; ARG-498; VAL-644; VAL-699; ASP-720; PHE-727 AND ASN-2105;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.